iShares China Large-Cap ETF vs Roivant Sciences Ltd. Common Shares — how do they compare? iShares China Large-Cap ETF trades at $33.9 (market cap $3.90B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 6.4× iShares China Large-Cap ETF's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, iShares China Large-Cap ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares China Large-Cap ETF for 149 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| FXI | ROIV | |
|---|---|---|
Market Cap | $3.90B | $25.09B |
Volume | 16,526,479 | 5,738,571 |
52-Week High | $41.08 | $41.81 |
52-Week Low | $31.59 | $16.04 |
Typical Hold Time | 149 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $21.36B |
Signals from Pluang's Aura AI — not financial advice
FXI (iShares China Large-Cap ETF) trades at $33.42, down 1.04% with a bearish technical outlook. The ETF shows compelling valuation at half the S&P 500's P/E ratio with a 1.98% yield, but faces headwinds from China's economic challenges and geopolitical tensions. Recent corporate profit growth of 26% in Q2 2026 provides fundamental support, though weak momentum persists amid global trade concerns.
The ETF offers diversification value and valuation appeal but carries significant political and economic risks. China's industrial overcapacity and weak domestic consumption create volatility, while U.S.-China relations remain a key variable. Institutional interest focuses on long-term value despite near-term bearish technical signals.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →